Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion

NEW YORK (AP) — Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion.

Copyright © 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Related Categories:

Business & Finance | National News

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up